Fig. 2From: Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysisForest plot of meta-analysis of mean reduction rate on T1-contrast enhanced MRI (a) and T2W FLAIR MRI (b) after bevacizumab (BV) treatment for radiation necrosis (RN) in patients with brain metastasesBack to article page